RenovoRx, Inc.
RNXT- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001574094
In the last 90 days, RenovoRx, Inc. insiders filed 1 open-market purchase and 0 sales; 40 institutions reported holding it in 13F filings for Q3 2026, worth $19.1M in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 18, 2026
- $54.0M
- Insider buysLast 90 days, $46.5K in total
- 1
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ3 2026, +12 vs. previous quarter
- 40
- 13F valueReported value at the end of Q3 2026
- $19.1M
- Superinvestors holdingAt the end of Q3 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $1.12M
- +2,511.6% year over year
- Net income, FY2025
- -$11.2M
- No comparable prior period
- Free cash flow, FY2025
- -$11.0M
- No comparable prior period
- Revenue, Q3 FY2026
- $1.07M
- +300.8% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Net loss for FY2025: $11.2M (994.5% of revenue).
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 998.0K
- Shares sold short
- Change
- +133.4K
- +15.4% vs. previous
- Days to cover
- 3.51
- At average daily volume
Superinvestors holding RNXT, Q3 2026
Go to the superinvestors tabNo superinvestor reported holding RNXT at the end of Q3 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by RenovoRx, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 17, 2026 (view filing)6:30 AM ET | Nov 16 | 1 day | Agah RamtinExecutive Chairman and CMO | PPurchase | +50.0K | $0.9297 | +$46.5K | +6.3%848.5K after | |
| May 21, 2026 (view filing) | May 19 | 2 days | Voll MarkChief Financial Officer | PPurchase | +25.0K | $0.79 | +$19.8K | +21.3%142.4K after | |
| Mar 24, 2026 (view filing) | Mar 20 | 4 days | Marton LaurenceDirector | PPurchase | +9.72K | – | – | New position9.72K after | |
| Mar 24, 2026 (view filing) | Mar 20 | 4 days | Marton LaurenceDirector | PPurchase | +4.86K | – | – | –4.86K after | Derivative |
| Mar 24, 2026 (view filing) | Mar 20 | 4 days | Bagai ShaunChief Executive Officer | PPurchase | +24.3K | – | – | +8.4%313.4K after | |
| Mar 24, 2026 (view filing) | Mar 20 | 4 days | Bagai ShaunChief Executive Officer | PPurchase | +12.2K | – | – | –12.2K after | Derivative |
| Mar 24, 2026 (view filing) | Mar 20 | 4 days | Voll MarkChief Financial Officer | PPurchase | +97.2K | – | – | New position97.2K after | |
| Mar 24, 2026 (view filing) | Mar 20 | 4 days | Voll MarkChief Financial Officer | PPurchase | +48.6K | – | – | –48.6K after | Derivative |
| Jan 22, 2026 (view filing) | Jan 21 | 1 day | Agah RamtinChief Medical Officer | PPurchase | +10.0K | $1.00 | +$10.0K | +1.3%798.5K after | |
| Jan 5, 2026 (view filing) | Dec 31, 2025 | 5 days | Agah RamtinChief Medical Officer | PPurchase | +9.79K | $0.86 | +$8.42K | +1.3%788.5K after |
Top 10 13F holders, Q3 2026
See all 40 holdersThe largest institutional positions in RenovoRx, Inc. at the end of Q3 2026; share changes are against Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| AIGH Capital Management LLC | 4,263,622 | $6.65M | 0.76% | −141,817−3.2% | Reduced |
| Vanguard Capital Management LLC | 1,668,360 | $2.60M | 0.00% | +224,618+15.6% | Added |
| Bleichroeder LP | 1,666,098 | $2.60M | 0.26% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 1,119,749 | $1.75M | 0.00% | +1,108,349+9,722.4% | Added |
| Geode Capital Management, LLC | 473,093 | $738.1K | 0.00% | +48,945+11.5% | Added |
| State Street Corp | 314,636 | $490.8K | 0.00% | +288,484+1,103.1% | Added |
| EAM Investors, LLC | 272,706 | $425.4K | 0.04% | +272,706 | New |
| Vanguard Fiduciary Trust Co | 269,916 | $421.1K | 0.00% | +29,586+12.3% | Added |
| Walleye Capital LLC | 262,106 | $408.9K | 0.00% | +262,106 | New |
| Wealthspire Advisors, LLC | 252,525 | $393.9K | 0.00% | 00.0% | Unchanged |
Holders of 5% or more of RNXT
See all 1 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of RenovoRx, Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Hirschman Orin | 13G/A | 9.80%4.43M shares | +2.70 ppfrom 7.10% | May 8, 20254 filings | Apr 27, 2026 | SEC |